Clinical Trial

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Name: A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer — clinical trial record (NCT07428044)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out how many people with HER2-amplified or HER2-mutated non-small cell lung cancer (NSCLC) experience a decrease in tumor viability when they receive trastuzumab deruxtecan before routine surgery to remove tumors.

Trial Details

NCT Number	NCT07428044
Lead Sponsor	Memorial Sloan Kettering Cancer Center Collaborators: AstraZeneca
Conditions	Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Stage II, Non-Small Cell Lung Cancer Stage IIIA, Non-Small Cell Lung Cancer Stage IIIB
Enrollment	14 participants
Start Date	2026-02-13
Primary Completion	2027-02-13 (estimated)
Study Completion	2027-02-13 (estimated)
Updated on ClinicalTrials.gov	2026-02-23